← Back to all clusters

Cluster 236

9 diseases · 18 shared-gene connections
9 Diseases
14 Unique genes
0.261 Avg. similarity score
Cardiofacial dysplasia Most-connected disease (6 links)
Log in to save this analysis

Save This Analysis

Disease Searched: Primary ciliary dyskinesia 14 Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
PRKACA 5 / 9 Cardioacrofacial dysplasia 1, Cardiofacial dysplasia, Ellis-van creveld syndrome, Multiple congenital malformation syndrome and 1 more
PRKACB 5 / 9 Cardioacrofacial dysplasia 2, Cardiofacial dysplasia, Ellis-van creveld syndrome, Male breast carcinoma and 1 more
CCDC170 2 / 9 Estrogen resistance, Male breast carcinoma
CCDC39 2 / 9 Ellis-van creveld syndrome, Primary ciliary dyskinesia 14
ESR1 2 / 9 Estrogen resistance, Male breast carcinoma
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Hedgehog signaling pathway KEGG 5 / 56 76.6× 3.56e-9 2.94e-7 ✓ sig.
Hedgehog 'off' state Reactome 4 / 56 61.3× 4.10e-7 1.92e-5 ✓ sig.
Vasopressin-regulated water reabsorption KEGG 3 / 44 58.5× 1.62e-5 4.37e-4 ✓ sig.
CREB1 phosphorylation through the activation of Adenylate Cyclase Reactome 2 / 7 245× 2.64e-5 6.54e-4 ✓ sig.
Endocrine and other factor-regulated calcium reabsorption KEGG 3 / 53 48.6× 2.85e-5 6.96e-4 ✓ sig.
Intraflagellar transport Reactome 3 / 54 47.7× 3.02e-5 7.29e-4 ✓ sig.
HDL assembly Reactome 2 / 8 214× 3.52e-5 8.26e-4 ✓ sig.
Hedgehog 'on' state Reactome 3 / 70 36.8× 6.59e-5 1.36e-3 ✓ sig.
Rap1 signalling Reactome 2 / 16 107× 1.50e-4 2.62e-3 ✓ sig.
Regulation of insulin secretion Reactome 2 / 16 107× 1.50e-4 2.62e-3 ✓ sig.
PKA activation in glucagon signalling Reactome 2 / 17 101× 1.70e-4 2.89e-3 ✓ sig.
Endocrine resistance KEGG 3 / 99 26.0× 1.85e-4 3.09e-3 ✓ sig.
Factors involved in megakaryocyte development and platelet production Reactome 3 / 99 26.0× 1.85e-4 3.09e-3 ✓ sig.
Activation of SMO Reactome 2 / 18 95.3× 1.91e-4 3.16e-3 ✓ sig.
DARPP-32 events Reactome 2 / 19 90.3× 2.13e-4 3.45e-3 ✓ sig.

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
negative regulation of smoothened signaling pathway GO:0045879 3 / 35 114× 2.16e-6 1.61e-4 ✓ sig.
vascular endothelial cell response to laminar fluid shear stress GO:0097700 2 / 9 297× 1.87e-5 8.78e-4 ✓ sig.
high-density lipoprotein particle assembly GO:0034380 2 / 10 267× 2.34e-5 1.04e-3 ✓ sig.
regulation of protein processing GO:0070613 2 / 11 243× 2.86e-5 1.20e-3 ✓ sig.
smoothened signaling pathway GO:0007224 3 / 94 42.6× 4.31e-5 1.65e-3 ✓ sig.
intraciliary retrograde transport GO:0035721 2 / 14 191× 4.72e-5 1.77e-3 ✓ sig.
regulation of osteoblast differentiation GO:0045667 2 / 17 157× 7.04e-5 2.38e-3 ✓ sig.
renal water homeostasis GO:0003091 2 / 19 141× 8.85e-5 2.83e-3 ✓ sig.
intraciliary transport GO:0042073 2 / 36 74.2× 3.24e-4 7.08e-3 ✓ sig.
positive regulation of smoothened signaling pathway GO:0045880 2 / 39 68.5× 3.80e-4 7.89e-3 ✓ sig.
protein localization to cilium GO:0061512 2 / 44 60.7× 4.84e-4 9.28e-3 ✓ sig.
cell projection organization GO:0030030 3 / 214 18.7× 4.91e-4 9.37e-3 ✓ sig.
cilium assembly GO:0060271 3 / 237 16.9× 6.61e-4 1.14e-2 ✓ sig.
notochord regression GO:0060032 1 / 1 1,335× 7.49e-4 1.23e-2 ✓ sig.
TORC1 signaling GO:0038202 2 / 67 39.8× 1.12e-3 1.55e-2 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
Cardiofacial dysplasia Multiple congenital malformation syndrome 0.667 2 8.34e-9 6.60e-8 ✓ sig.
Estrogen resistance Male breast carcinoma 0.286 2 2.50e-7 1.65e-6 ✓ sig.
Ellis-van creveld syndrome Multiple congenital malformation syndrome 0.200 2 3.00e-7 1.96e-6 ✓ sig.
Cardiofacial dysplasia Ellis-van creveld syndrome 0.200 2 3.00e-7 1.96e-6 ✓ sig.
Cardioacrofacial dysplasia 1 Primary pigmented nodular adrenocortical disease 4 0.500 1 6.46e-5 1.98e-4 ✓ sig.
Cardioacrofacial dysplasia 1 Cardiofacial dysplasia 0.333 1 1.29e-4 3.27e-4 ✓ sig.
Multiple congenital malformation syndrome Primary pigmented nodular adrenocortical disease 4 0.333 1 1.29e-4 3.27e-4 ✓ sig.
Cardiofacial dysplasia Primary pigmented nodular adrenocortical disease 4 0.333 1 1.29e-4 3.27e-4 ✓ sig.
Cardioacrofacial dysplasia 2 Multiple congenital malformation syndrome 0.333 1 1.29e-4 3.27e-4 ✓ sig.
Cardioacrofacial dysplasia 2 Cardiofacial dysplasia 0.333 1 1.29e-4 3.27e-4 ✓ sig.
Cardioacrofacial dysplasia 1 Multiple congenital malformation syndrome 0.333 1 1.29e-4 3.27e-4 ✓ sig.
Cardioacrofacial dysplasia 2 Male breast carcinoma 0.167 1 3.23e-4 6.41e-4 ✓ sig.
Cardioacrofacial dysplasia 2 Ellis-van creveld syndrome 0.100 1 5.81e-4 1.00e-3 ✓ sig.
Cardioacrofacial dysplasia 1 Ellis-van creveld syndrome 0.100 1 5.81e-4 1.00e-3 ✓ sig.
Ellis-van creveld syndrome Primary ciliary dyskinesia 14 0.100 1 5.81e-4 1.00e-3 ✓ sig.
Ellis-van creveld syndrome Primary pigmented nodular adrenocortical disease 4 0.100 1 5.81e-4 1.00e-3 ✓ sig.
Cardiofacial dysplasia Male breast carcinoma 0.143 1 6.46e-4 1.09e-3 ✓ sig.
Male breast carcinoma Multiple congenital malformation syndrome 0.143 1 6.46e-4 1.09e-3 ✓ sig.